Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Clinical trial NCT03977233 · RECRUITING

Trial details

NCT number: NCT03977233
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)Cancer of Pancreas Pancreatic Cancer, Adult Pancreas Adenocarcinoma Pancreatic Neoplasms Pancreatic Cancer Non-resectable Pancreatic Cancer Resectable

Start date: 2019-06-12
Primary completion: 2027-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.